Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas

Similar documents
Pandemic (H1N1) (August 14, h GMT; 12 h EST) Update on the Qualitative Indicators

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009

Regional Update Pandemic (H1N1) 2009 (January 19, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (March 15, h GMT; 12 h EST)

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

Regional Update Pandemic (H1N1) 2009 (December 1, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 31, h GMT; 17 h EST) Update on the Qualitative Indicators Epidemiological Week 29 intensity

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Special Topic. The ten leading causes of death in countries of the Americas

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

countries do not have information available for this indicator.

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Figure 1: Case Distribution of Dengue Hemorrhagic Fever, in %, by subregion, *This includes cases of dengue with complications.

Regional Update Pandemic (H1N1) 2009 (May 24, h GMT; 12 h EST)

ASSESSMENT OF IMPACTS OF AIR POLLUTION ON HEALTH

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH

ZIKA VIRUS WHAT IS THE SITUATION IN SINGAPORE? 6 September 2016

PUBLIC HEALTH UPDATE

Epidemiological Update Dengue

Zika virus transmission: ECDC adaptation of WHO's Zika virus country classification scheme 1

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Country Length Discount Travel Period Anguilla All 20% off 08/24/11 12/15/11 Antigua All 20% off 08/24/11 12/15/11 Argentina All 20% off 08/24/11

Regional Update Influenza (August 16, h GMT; 12 h EST)

FIRST CONFIRMED CASE OF IMPORTED ZIKA VIRUS IN HOUSTON, TEXAS. Preventing Transmission

SLV Health Blood Drive

HEALTH ORGANIZATION. ORGANIZATION XXXIX Meeting Washington, D.C. September 1996

Human Papillomavirus and Related Cancers

r0 HEALTH HEALTH ORGANIZATION ORGANIZATION XXXIX Meeting Washington, D.C. September 1996 XLVIII Meeting Provisional Agenda Item 5.

Anton Best, MBBS, MPH&TM, MPA Senior Medical Officer of Health, HIV/ STI Programme, Ministry of Health, Barbados

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

Epidemiology and Response Datapack

Terms and Conditions. VISA Global Customer Assistance Services

Influenza Vaccine Use In the Americas

Zika Virus. Public Information Update/phone script. Date: March 28, 2016 Time: 11:00 a.m.

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan

Epidemiological Alerts and Updates. Annual Report

First, Last Name DOB: Maternal Risk Questionnaire (MRQ)

Tobacco Control Report for the Region of the Americas

FOURTH ANNUAL VACCINATION WEEK IN THE AMERICAS (VWA 2006) FINAL REPORT

Regional Updates on CVD Trends and Actions: Latin America and the Caribbean

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

2010 Situation Analysis Elimination of Mother-to-child Transmission of HIV and Congenital Syphilis in the Americas

Acute Public Health Events Assessed by WHO Regional Offices for Africa, the Americas, and Europe under the International Health Regulations (2005)

Diabetes Advocacy Experience

55th DIRECTING COUNCIL

Health for All THE EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS: A REVIEW

2007 Port of Spain Summit Compliance: Tobacco Advertising to Children

CARIBBEAN SEMINAR ON TOBACCO AND TRADE

_flu.asp. region States. North. The Caribbean and. South. region. South

REPORT ON COMMUNICABLE DISEASES

Translating Science to End HIV in Latin America and the Caribbean

First, Last Name: DOB: F91148 Maternal Risk Questionnaire

Everything you ever wanted to know about Zika Virus Disease

Regional Update EW 09 Influenza (March 15, h GMT; 12 h EST)

ZIKA VIRUS MICROCEPHALY AND GUILLAIN-BARRÉ SYNDROME

46th DIRECTING COUNCIL 57th SESSION OF THE REGIONAL COMMITTEE

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

CHOLERA Emergency needs in the Caribbean

Implementation of the Caribbean Cancer Registry Hub

Offshore Biological Control Strategy Applied to Pink Hibiscus Mealybug. Dale E. Meyerdirk USDA, APHIS, PPQ Riverdale, MD

Chikungunya: Perspectives and Trends Global and in the Americas. Presenter: Dr. Eldonna Boisson PAHO/WHO

PAHO HIV REPORT. Progress of Implementation of the World Health Organization. Drug Resistance Strategy. in Latin America and the Caribbean:

Marta-Louise Ackers, a Robert E Quick, a Christopher J Drasbek, b Lori Hutwagner c and Robert V Tauxe a

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience

Response to the Epidemic of Zika Virus in the Americas

Washington, D.C. September-October 1993

CD29/23 Page 2. (Eng.) EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS. Progress Report by the Director. 1. Background and Policy Basis

Epidemiology of AIDS and HIV Infection in the Caribbean

Preventing disease Promoting and protecting health

DEMENTIA IN THE AMERICAS. CURRENT AND FUTURE COST AND PREVALENCE OF ALZHEIMER S DISEASE AND OTHER DEMENTIAs. bupa.com/dementia alz.co.

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

LEADING A HEART TEAM: ESSENTIAL LEADERHIP SKILLS FOR EVERY CARDIOLOGIST. Richard Ishmael MBBS, FACC. President, Caribbean Cardiac Society.

Main developments in past 24 hours

PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION. directing council 6NDEXED. regional committee. XXXVII Meeting

Regional Update EW 31, 2014 Influenza and other respiratory viruses (August 12, 2014)

Human Papillomavirus and Related Diseases Report AMERICAS

Pacific Telecom Inc. (PTI) Message Telecommunications Service Table of General Rates

Regional Update EW 32, 2012 Influenza (August 21, h GMT; 12 h EST)

105th Meeting Washington, D.C. June Provisional Agenda Item 4.3 CE105/7 (Eng.) 18 April 1990 ORIGINAL; ENGLISH

General Description. Significance

Regional Update EW 43 Influenza (November 8, h GMT; 12 h EST)

Current Status on the implementation of TB- HIV collaborative activities in the Americas. Results of a survey in the countries of the Region

Building Zika preparedness in the Region of the Americas: research response

Doral Police Department - Office of Emergency Management. Action Plan Zika Virus Prevention, Preparedness and Outreach Date: Feb.

Regional Update EW 30 Influenza (August 9, h GMT; 12 h EST)

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Prevalence of Alcohol Consumption during Pregnancy and Fetal Alcohol Spectrum Disorder

Regional Update EW 14, 2013 Influenza and other respiratory viruses (April 16, 2013)

Regional Update EW 22, 2013 Influenza and other respiratory viruses (June 11, 2013)

Barbados. Tobacco Control Report Current Tobacco Use Prevalence 34.5% 23.2% 13%

V3P: Region Fact Sheet

Hearing loss in persons 65 years and older based on WHO global estimates on prevalence of hearing loss

Regional Update EW 41 Influenza (October 25, h GMT; 12 h EST)

Regional Vaccination Plan. in Case of Influenza Pandemic

Overview of Zika. Alan D.T. Barrett Department of Pathology Sealy Center for Vaccine Development University of Texas Medical Branch Galveston TX

MESOAMERICAN MASTER PLAN FOR THE INTEGRATED MANAGEMENT OF DENGUE AND CHIKUNGUNYA PREVENTION AND CONTROL

Photo: Barbados VWA 2015 VACCINATION WEEK IN THE AMERICAS 2015 FINAL REPORT. Boost your power! Get Vaccinated!

Non-Communicable Diseases in the Caribbean Region

Transcription:

Investigating Disease Epidemics through Simulation with a focus on Chikungunya in the Americas Alexandra L. Stone and Jean C. Galan-Rivera Mentors: Dr. Jacob Oleson and Dr. Grant Brown ISIB 2015 University of Iowa College of Public Health July 17th, 2015

Agent Based Models An agent-based model (ABM) is a computational model that simulates the actions and interactions of autonomous agents to observe the effects on a system. Agents can take a number of forms, depending on the granularity of the available data (how the data is given), and computational feasibility. Examples could be an agent that represent individual members of a population, administrative regions, farms, or other domain specific units of interest. The goal of this ABM is to see how an infectious disease spreads through agents in a population over time.

Conway s Game of Life To understand how an agent-based model works, we run a Conway s Game of Life Simulation. Is a 2-D grid (population) composed of square cells (agents). Each cell has two possible states: alive or dead. Each cell interacts with its 8 neighbors. There are 4 Rules that determine whether the cell is alive or dead: 1. Any live cell with fewer than two live neighbors dies, as if caused by under-population. 2. Any live cell with two or three live neighbors lives on to the next generation. 3. Any live cell with more than three live neighbors dies, as if by overcrowding. 4. Any dead cell with exactly three live neighbors becomes a live cell, as if by reproduction.

Disease Simulation Is a 2-D grid of square cells. Each cell represents an amount of people with two possible states: infected or non-infected, and each cell interacts with its 8 neighbors. For this simulation, we infect some people in the center of the grid. By a specific probability function we will see how the disease will spread through the grid. This probability function depends of two infectious coefficients, the first determine often the people will be infected by the people that is infected on the same cell; the second will tell how much the people will be infected by the infected surroundings. Then we will see how the disease gets removed from the people by a removing probability function. We can change the infectious coefficients and the probability of removing the disease and will see different effects on the simulation.

About Chikungunya The data is from PAHO. Case Definition: Clinical Criteria: acute onset of fever >101.3 F and severe arthralgia/arthritis not explained by other medical conditions. Epidemiological criteria: residing or having visited epidemic areas, having reported transmission within 15 days prior to the onset of symptoms. Virus that is transmitted to people by two different mosquitoes: Aedes aegypti and Aedes albopictus. Most common symptoms are fever and joint pain. It first appearances on Africa, Asia, Europe and Oceania. It was found for the first time in the Americas on Caribbean Islands. For this project we will focus on how the Chikungunya has spread on the Americas.

How Many Individuals Have Been Infected per Country

Summary Statistics of Chikungunya Region Mean per Week Standard Deviation per Week Anguilla 1.818 3.068 Antigua and Barbuda 26.291 49.580 Argentina 0.818 1.124 Aruba 9.018 15.504 Bahamas 1.800 3.817 Barbados 32.764 59.528 Belize 0.091 0.290 Bermuda 0.182 0.580 Bolivi 0.091 0.290 Bonaire 0.000 0.000 Brazil 56.927 169.61 Canada 1.600 5.213 Cayman Islands 3.945 10.213 Chile 0.345 1.518 Colombia 2219.982 5357.882 Costa Rica 2.345 5.739 Cuba 0.273 0.622 Curacao 48.764 113.314 Dominica 68.400 103.788 Dominican Republic 9805.145 13059.122 Ecuador 0.182 0.580 El Savador 2461.527 5938.001 Falkland Islands 0.000 0.000 French Guiana 255.855 423.589 Grenada 56.345 123.765 Guadaloupe 1484.273 1796.431 Guatemala 506.000 1323.422 Guyana 96.836 352.685 Haiti 1176.564 3026.685

Summary Statistics of Chikungunya Region Mean per Week Standard Deviation per Week Honduras 101.527 262.472 Jamaica 30.582 46.410 Martinique 1340.655 1007.475 Mexico 3.582 10.177 Montserrat 2.273 6.072 Nicaragua 84.782 196.198 Panama 0.982 1.545 Paraguay 0.145 0.356 Peru 0.527 1.26 Puerto Rico 470.909 597.697 Saba 0.000 0.000 Saint Barthelemy 27.909 35.001 Saint Kitts and Nevis 8.364 23.098 Saint Lucia 16.109 32.854 Saint Martin French Part 102.127 203.636 Saint Vincent and Grenadines 25.364 51.968 Sint Eustatius 0.000 0.000 Sint Maarten Dutch Part 8.582 13.168 Suriname 22.236 44.088 Trinidad and Tobago 5.364 8.685 Turks and Caicos Islands 0.455 0.878 United States Of America 42.582 43.915 Uruguay 0.000 0.000 Venezuela 675.255 1716.756 Virgin Islands UK 7.145 20.113 Virgin Islands US 29.236 43.248

Number of Cases vs. Weeks per Country

We considered the first 30 weeks for the simulation because after the 30 weeks there was a clear shift in the disease dynamics. This could be due to multiple reasons: Public Health awareness Seasonal Like the first Disease Simulations we saw earlier, we will take the baseline data and run the simulation. For this one we will consider the distance between the countries since the surroundings of the countries are different from the surroundings of the 2-D grid. For this simulation we are just considering space (countries), time (weeks), and distance (between countries), we do not consider the mosquitoes and other factors.

Interactive Map of Chikungunya from Simulation

Future Works Find, if possible, a better simulation which describes the data for each country for the first weeks. Do the same we have done but with the other part of the data (last 25 weeks). Describe the data for other continents. Look at other factors that could influence the spread of Chikungunya.

References "Chikungunya." Pan American Health Organization and World Health Organization. Pan American Health Organization. Web. 15 July 2015. <http://www.paho.org/hq/ index.php?itemid=40931>. "Chikungunya Virus." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 15 June 2015. Web. 15 July 2015. <http://www.cdc.gov/ chikungunya/>. "Conway's Game of Life." Wikipedia. Wikimedia Foundation, 30 June 2015. Web. 15 July 2015. R version 3.1.1 (2014-07-10) -- "Sock it to Me Copyright (C) 2014 The R Foundation for Statistical Computing Platform: x86_64-apple-darwin13.1.0 (64- bit)

We want to give thanks to the NIH and the University of Iowa ISIB Program sponsored by the Na5onal Heart Lung and Blood Ins5tute (NHLBI) T15 HL097622

Questions